Shire bets big on rare diseases
Monday, January 18, 2016 - 07:30
in Biology & Nature
$32bn Baxalta buyout will deepen Shire’s commitment to developing specialist drugs for small patient populations
$32bn Baxalta buyout will deepen Shire’s commitment to developing specialist drugs for small patient populations